Medindia

X

FDA Media Briefing on Asthma Drugs

Friday, February 19, 2010 Drug News J E 4
Advertisement

** CREDENTIALED PRESS ONLY **

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

WHAT:

A media briefing on new safety controls for long-acting beta agonists, medications used to treat asthma

WHO:

--Janet Woodcock, M.D., director, Center for Drug Evaluation and Research (CDER), FDA

--John Jenkins, M.D., director, Office of New Drugs, CDER, FDA

--Gerald Dal Pan, M.D., director, Office of Surveillance and Epidemiology, CDER, FDA

--Badrul Chowdhury, M.D., director, Division of Pulmonary and Allergy Products, Office of Drug Evaluation II, CDER, FDA

--Sally Seymour, M.D., deputy director for safety, Division of Pulmonary and Allergy Products, Office of Drug Evaluation II, CDER

WHEN:

Thurs., Feb. 18, 2010, 1:15 p.m. EST

HOW:

Reporters may participate in a listen-only mode by dialing 888-455-0031 or for international reporters, 1-312-470-0068. The password for all callers is "FDA." A replay of the briefing will be available until Feb. 25 by calling 888-562-2793 or for international reporters, 1-402-998-1450.

CONTACT: Karen Riley, 301-796-4674 (office), karen.riley@fda.hhs.gov, or Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov, both of FDA

/PRNewswire-USNewswire -- Feb. 18/

SOURCE U.S. Food and Drug Administration

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds The Future of R&D Outsourcing: I...
S
Reportlinker Adds Sodium Borohydride Market in Chi...